Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab

Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab

Abstract The early remission of diabetic macular edema (DME) often occurs in eyes treated with anti-vascular endothelial growth factor (VEGF) treatment. We retrospectively reviewed and characterized eyes with early remission of DME at six months in 80 eyes under pro re nata (PRN) intravitreal ranibi...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatsuya Yoshitake, Tomoaki Murakami, Kiyoshi Suzuma, Masahiro Fujimoto, Yoko Dodo, Akitaka Tsujikawa
Format: article
Language:EN
Published: Nature Portfolio 2019
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/4e45db775cc64c1a91f4546776fa7729
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items